-
Je něco špatně v tomto záznamu ?
Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism
KG. Calderon-González, I. Medina-Medina, L. Haronikova, L. Hernychova, O. Bonczek, L. Uhrik, V. Hrabal, B. Vojtesek, R. Fahraeus, J. Hernández-Monge, V. Olivares-Illana
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2012-08-01
Freely Accessible Science Journals
od 2012-08-01
PubMed Central
od 2012
Europe PubMed Central
ProQuest Central
od 2021-01-01
Open Access Digital Library
od 2012-01-01
Medline Complete (EBSCOhost)
od 2008-02-01
Health & Medicine (ProQuest)
od 2021-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1981
PubMed
35674210
DOI
10.1042/bsr20220186
Knihovny.cz E-zdroje
- MeSH
- jaderné proteiny genetika MeSH
- messenger RNA metabolismus MeSH
- nádorový supresorový protein p53 * genetika metabolismus MeSH
- proteiny buněčného cyklu metabolismus MeSH
- protoonkogenní proteiny c-mdm2 * genetika metabolismus MeSH
- protoonkogenní proteiny genetika MeSH
- serin metabolismus MeSH
- ubikvitin genetika MeSH
- ubikvitinace MeSH
- ubikvitinligasy genetika metabolismus MeSH
- vazba proteinů MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
HDMX and its homologue HDM2 are two essential proteins for the cell; after genotoxic stress, both are phosphorylated near to their RING domain, specifically at serine 403 and 395, respectively. Once phosphorylated, both can bind the p53 mRNA and enhance its translation; however, both recognize p53 protein and provoke its degradation under normal conditions. HDM2 has been well-recognized as an E3 ubiquitin ligase, whereas it has been reported that even with the high similarity between the RING domains of the two homologs, HDMX does not have the E3 ligase activity. Despite this, HDMX is needed for the proper p53 poly-ubiquitination. Phosphorylation at serine 395 changes the conformation of HDM2, helping to explain the switch in its activity, but no information on HDMX has been published. Here, we study the conformation of HDMX and its phospho-mimetic mutant S403D, investigate its E3 ligase activity and dissect its binding with p53. We show that phospho-mutation does not change the conformation of the protein, but HDMX is indeed an E3 ubiquitin ligase in vitro; however, in vivo, no activity was found. We speculated that HDMX is regulated by induced fit, being able to switch activity accordingly to the specific partner as p53 protein, p53 mRNA or HDM2. Our results aim to contribute to the elucidation of the contribution of the HDMX to p53 regulation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025132
- 003
- CZ-PrNML
- 005
- 20250109080402.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1042/BSR20220186 $2 doi
- 035 __
- $a (PubMed)35674210
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Calderon-González, Karla Gisel $u Laboratorio de Interacciones Biomoleculares y cáncer. Instituto de Física Universidad Autónoma de San Luis Potosí, Av. Parque Chapultepec 1570, Privadas del pedregal, 78210, SLP, México
- 245 10
- $a Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism / $c KG. Calderon-González, I. Medina-Medina, L. Haronikova, L. Hernychova, O. Bonczek, L. Uhrik, V. Hrabal, B. Vojtesek, R. Fahraeus, J. Hernández-Monge, V. Olivares-Illana
- 520 9_
- $a HDMX and its homologue HDM2 are two essential proteins for the cell; after genotoxic stress, both are phosphorylated near to their RING domain, specifically at serine 403 and 395, respectively. Once phosphorylated, both can bind the p53 mRNA and enhance its translation; however, both recognize p53 protein and provoke its degradation under normal conditions. HDM2 has been well-recognized as an E3 ubiquitin ligase, whereas it has been reported that even with the high similarity between the RING domains of the two homologs, HDMX does not have the E3 ligase activity. Despite this, HDMX is needed for the proper p53 poly-ubiquitination. Phosphorylation at serine 395 changes the conformation of HDM2, helping to explain the switch in its activity, but no information on HDMX has been published. Here, we study the conformation of HDMX and its phospho-mimetic mutant S403D, investigate its E3 ligase activity and dissect its binding with p53. We show that phospho-mutation does not change the conformation of the protein, but HDMX is indeed an E3 ubiquitin ligase in vitro; however, in vivo, no activity was found. We speculated that HDMX is regulated by induced fit, being able to switch activity accordingly to the specific partner as p53 protein, p53 mRNA or HDM2. Our results aim to contribute to the elucidation of the contribution of the HDMX to p53 regulation.
- 650 _2
- $a proteiny buněčného cyklu $x metabolismus $7 D018797
- 650 _2
- $a jaderné proteiny $x genetika $7 D009687
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a protoonkogenní proteiny $x genetika $7 D011518
- 650 12
- $a protoonkogenní proteiny c-mdm2 $x genetika $x metabolismus $7 D051736
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a serin $x metabolismus $7 D012694
- 650 12
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 650 _2
- $a ubikvitin $x genetika $7 D025801
- 650 _2
- $a ubikvitinligasy $x genetika $x metabolismus $7 D044767
- 650 _2
- $a ubikvitinace $7 D054875
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Medina-Medina, Ixaura $u Laboratorio de Interacciones Biomoleculares y cáncer. Instituto de Física Universidad Autónoma de San Luis Potosí, Av. Parque Chapultepec 1570, Privadas del pedregal, 78210, SLP, México
- 700 1_
- $a Haronikova, Lucia $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Hernychova, Lenka $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Bonczek, Ondřej, $d 1986- $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $7 xx0327493
- 700 1_
- $a Uhrik, Lukas $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Hrabal, Vaclav $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Vojtesek, Borivoj $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Fahraeus, Robin $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Department of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden $u Équipe Labellisée Ligue Contre le Cancer, Université Paris 7, INSERM UMR 1162, 27 Rue Juliette Dodu, 75010 Paris, France
- 700 1_
- $a Hernández-Monge, Jesús $u Catedra CONACyT- Laboratorio de Biomarcadores Moleculares. Instituto de Física, Universidad Autónoma de San Luis Potosí, México City, México
- 700 1_
- $a Olivares-Illana, Vanesa $u Laboratorio de Interacciones Biomoleculares y cáncer. Instituto de Física Universidad Autónoma de San Luis Potosí, Av. Parque Chapultepec 1570, Privadas del pedregal, 78210, SLP, México $1 https://orcid.org/0000000169495986
- 773 0_
- $w MED00000783 $t Bioscience reports $x 1573-4935 $g Roč. 42, č. 7 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35674210 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20250109080356 $b ABA008
- 999 __
- $a ok $b bmc $g 1854703 $s 1176422
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 42 $c 7 $e 20220729 $i 1573-4935 $m Bioscience reports $n Biosci Rep $x MED00000783
- LZP __
- $a Pubmed-20221017